Skip to main content
European Commission logo print header

Molecular mechanism of macrolide antibiotic action and resistance: application in drug development

Objectif

the present number one threat to human health is recognized as being the previously unseen levels of multiple antibiotic resistances that exist in bacterial pathogens. The development of new antibiotics is of crucial importance. Unfortunately, the mechanism of action of commonly used antibiotics is not fully understood. Understanding the molecular mechanisms of antibiotic action and resistance will make the rational design of new drugs possible. We aim to elucidate the structural origins for the action and resistance of a class of antibiotics, the macrolides.They interact with the RNA component of ribosomes and inhibit protein synthesis. The latest generation of macro ides, the deltoids, exhibit high activity againstmacrolides-resistant bacterial strains . A combination of genetic , biochemical and structural tools originating from different groups will be use used. Structural data will be essential for the development of new therapeutic agents.

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

Centre National de la Recherche Scientifique (CNRS)
Contribution de l’UE
Aucune donnée
Adresse
Avenue de la Terrasse
91198 Gif-sur-Yvette
France

Voir sur la carte

Coût total
Aucune donnée

Participants (2)